Abingworth Portfolio 2026

Abingworth accounts for 31 tracked companies with verified cap-table data, 31 of which disclose round sizes totalling $7.1B. The median disclosed raise is $120M, and the largest is Vaxcyte at $2.4B, ahead of Tubulis ($575M) and AdvanCell ($440M).

The names that recur most often on these portfolio cap tables are Abingworth (31 companies), Osage University Partners (5 companies), Atlas Venture (5 companies), 4BIO Capital (4 companies), Surveyor Capital (4 companies), Omega Funds (4 companies). By latest disclosed round, the market skews Series A (15), Series B (7), Series C (2), IPO (1).

• Companies tracked: 31
• Disclosed funding total: $7.1B across 31 companies
• Median disclosed raise: $120M
• Largest raise: Vaxcyte — $2.4B
• Stage mix: Series A 15 · Series B 7 · Series C 2 · IPO 1
• Most recent dated round: 2026-05-20

Best funded Abingworth companies

1. Vaxcyte — $2.4B (latest: IPO)
2. Tubulis — $575M (latest: Series A)
3. AdvanCell — $440M (latest: Series D)
4. Gynesonics — $338M (latest: Series F)
5. Effector Therapeutics — $325M (latest: Series A)
6. GenSight Biologics — $264M
7. Escient Pharmaceuticals — $238M (latest: Series C)
8. Attralus — $201M (latest: Series B)
9. Wugen — $200M (latest: Series B)
10. cAMPfield Therapeutics — $180M (latest: Series A)
11. Timberlyne Therapeutics — $180M (latest: Series A)
12. Antares Therapeutics — $177M (latest: Series A)
13. Chiasma — $161M
14. Ascend — $130M (latest: Series A)
15. Ascend Advanced Therapies — $130M (latest: Series A)

Abingworth — related firms and companies (56)

• Vaxcyte
• Tubulis
• AdvanCell
• Gynesonics
• Effector Therapeutics
• GenSight Biologics
• Escient Pharmaceuticals
• Attralus
• Investors like Torch Capital
• Investors like Canaan Partners
• Investors like Script Capital
• Investors like SOSV
• Investors like Trinity Ventures
• Investors like AME Cloud Ventures
• Investors like General Catalyst
• Investors like Thrive Capital
• Investors like Menlo Ventures
• Investors like StepStone Group
• Investors like Flybridge
• Investors like GIC
• Investors like B Capital
• Investors like Index Ventures
• Investors like Motivate Venture Capital
• Investors like Foundation Capital
• Investors like Ribbit Capital
• Investors like Atlas Venture
• Investors like Blockchain Capital
• Investors like Digital Currency Group
• Investors like Google Ventures
• Founders backed by Abingworth
• Companies backed by Abingworth
• Investors like Abingworth
• Abingworth co-investors 2026
• Avila Therapeutics
• Pixium Vision
• Venatorx Pharmaceuticals, Inc.
• IFM Therapeutics
• Anjarium Biosciences
• Q32 Bio
• Ascend Gene & Cell Therapies
• Personalis
• R1 Therapeutics
• Entact Bio
• Cytospire Therapeutics
• Reneo Pharmaceuticals
• Addition Therapeutics
• Nido Biosciences
• Myricx Bio
• Solve Therapeutics
• Ascend Advanced Therapies
• Ascend
• Chiasma
• Antares Therapeutics
• Timberlyne Therapeutics
• cAMPfield Therapeutics
• Wugen

Abingworth profile · All research reports